These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2956880)
1. Current views on the pathophysiology and investigations of thrombotic disorders. Salem HH; Mitchell CA; Firkin BG Am J Hematol; 1987 Aug; 25(4):463-74. PubMed ID: 2956880 [No Abstract] [Full Text] [Related]
2. Hypercoagulability and thrombosis. Bick RL; Ucar K Hematol Oncol Clin North Am; 1992 Dec; 6(6):1421-31. PubMed ID: 1452521 [TBL] [Abstract][Full Text] [Related]
3. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction. Gram J Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835 [TBL] [Abstract][Full Text] [Related]
4. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations. Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154 [TBL] [Abstract][Full Text] [Related]
5. Hemostasis in the mouse (Mus musculus): a review. Tsakiris DA; Scudder L; Hodivala-Dilke K; Hynes RO; Coller BS Thromb Haemost; 1999 Feb; 81(2):177-88. PubMed ID: 10063988 [No Abstract] [Full Text] [Related]
7. Coagulation and thromboembolic complications in the nephrotic syndrome. Cameron JS Adv Nephrol Necker Hosp; 1984; 13():75-114. PubMed ID: 6433673 [No Abstract] [Full Text] [Related]
8. Level of antithrombin III, protein C, protein S and other selected parameters of coagulation and fibrinolysis in the blood of the patients with recurrent deep venous thrombosis. Swiatkiewicz A; Jurkowski P; Kotschy M; Ciecierski M; Jawień A Med Sci Monit; 2002 Apr; 8(4):CR263-8. PubMed ID: 11951068 [TBL] [Abstract][Full Text] [Related]
9. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis. Alving BM; Comp PC Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444 [TBL] [Abstract][Full Text] [Related]
10. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Llach F Kidney Int; 1985 Sep; 28(3):429-39. PubMed ID: 3906225 [No Abstract] [Full Text] [Related]
11. Effect of dihydroergotamine on coagulation factors and components of the fibrinolytic system. Svanberg L; Bernstein K; Kullander S; Astedt B Acta Obstet Gynecol Scand; 1980; 59(3):251-3. PubMed ID: 6158827 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for thrombosis in lupus patients. Hasselaar P; Derksen RH; Blokzijl L; Hessing M; Nieuwenhuis HK; Bouma BN; De Groot PG Ann Rheum Dis; 1989 Nov; 48(11):933-40. PubMed ID: 2512863 [TBL] [Abstract][Full Text] [Related]
14. The hypercoagulable states. Schafer AI Ann Intern Med; 1985 Jun; 102(6):814-28. PubMed ID: 3158262 [TBL] [Abstract][Full Text] [Related]
15. The natural anticoagulants. Salem HH Clin Haematol; 1986 May; 15(2):371-91. PubMed ID: 3015466 [No Abstract] [Full Text] [Related]
16. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. High KA Arch Pathol Lab Med; 1988 Jan; 112(1):28-36. PubMed ID: 2962557 [TBL] [Abstract][Full Text] [Related]
17. Lupus-like anticoagulants, modulation of the protein C pathway and thrombosis. Freyssinet JM; Cazenave JP Thromb Haemost; 1987 Aug; 58(2):679-81. PubMed ID: 3118497 [No Abstract] [Full Text] [Related]